Abstract
The prevalence of HIV/hepatitis C virus (HCV) coinfection in Spain is one of the highest since both these infections share routes of transmission. Resolution of HCV in coinfected patients depends on HCV genotype and treatment. The recommended treatment consisted of subcutaneous administration of pegylated interferon and oral ribavirin. Treatment is administered for a specific period (from 6 months to 1 year), but has secondary effects that limit the patient’s daily life and require a health education process. The PRECEDE method can be used to make individual and group behavioral diagnoses that aim to effect changes in patients’ behavior, attitudes and knowledge. An accurate preintervention behavioral diagnosis guarantees the suitability and effectiveness of interventions to support HIV/HCV coinfected individuals in treatment adherence.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
